Tax Provision - Kilitch Drugs (India) Ltd (NSE:KILITCH) - Alpha Spread
K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 335.1 INR -0.76% Market Closed
Market Cap: 5.4B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Tax Provision Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Tax Provision
-â‚ą59.2m
CAGR 3-Years
-39%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Tax Provision
-â‚ą16.7B
CAGR 3-Years
-28%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Tax Provision
-â‚ą16B
CAGR 3-Years
-19%
CAGR 5-Years
-22%
CAGR 10-Years
-15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Tax Provision
-â‚ą15.2B
CAGR 3-Years
-32%
CAGR 5-Years
-18%
CAGR 10-Years
-7%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Tax Provision
-â‚ą12B
CAGR 3-Years
-73%
CAGR 5-Years
-20%
CAGR 10-Years
-24%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Tax Provision
-â‚ą7.4B
CAGR 3-Years
-29%
CAGR 5-Years
-44%
CAGR 10-Years
-12%

See Also

What is Kilitch Drugs (India) Ltd's Tax Provision?
Tax Provision
-59.2m INR

Based on the financial report for Jun 30, 2024, Kilitch Drugs (India) Ltd's Tax Provision amounts to -59.2m INR.

What is Kilitch Drugs (India) Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
-9%

Over the last year, the Tax Provision growth was -49%. The average annual Tax Provision growth rates for Kilitch Drugs (India) Ltd have been -39% over the past three years , -9% over the past five years .

Back to Top